{"title":"The evaluation of the inflammatory parameters in the patients with controlled epilepsy versus the patients with resistant epilepsy","authors":"Tülin Gesoglu Demir, Ozlem Ethemoglu, Dilek Agırcan","doi":"10.54029/2023aej","DOIUrl":null,"url":null,"abstract":"Objective: This study aims to evaluate the effects of C-reactive protein (CRP), albümin, mean platelet volume (MPV) values and neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLO), MPV/PLT ratio, CRP / Albumin ratios on seizure type and seizure control in epilepsy patients who are refractory or non-refractory to treatments. Methods: The study comprised 43 refractory epilepsy, 64 well-controlled epilepsy patients and control group including 68 healthy individuals. Mean platelet volume (MPV), platelet, CRP, and albumin values of the patients were studied. CRP / albumin ratio (CAR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLO), and the MPV/ PLT ratio were determined. Results: The mean serum CRP and CAO were found to be significantly higher in refractory epilepsy patients compared to well-controlled epilepsy patients and healthy control groups, while MPV and albumin levels were found to be significantly lower. Conclusions: Serum CRP and CAO were found to be significantly higher in refractory epilepsy patients compared to well-controlled epilepsy patients and healthy control groups, while MPV and albumin levels were found to be significantly lower. In addition, this inflammatory activity increases as the frequency of seizures increases and the duration of the disease increases. These findings suggest that increased inflammatory response may affect the patient’s prognosis. In light of these findings, we think new treatment strategies that control the inflammatory response are necessary for patients with refractory epilepsy.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"45 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54029/2023aej","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study aims to evaluate the effects of C-reactive protein (CRP), albümin, mean platelet volume (MPV) values and neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLO), MPV/PLT ratio, CRP / Albumin ratios on seizure type and seizure control in epilepsy patients who are refractory or non-refractory to treatments. Methods: The study comprised 43 refractory epilepsy, 64 well-controlled epilepsy patients and control group including 68 healthy individuals. Mean platelet volume (MPV), platelet, CRP, and albumin values of the patients were studied. CRP / albumin ratio (CAR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLO), and the MPV/ PLT ratio were determined. Results: The mean serum CRP and CAO were found to be significantly higher in refractory epilepsy patients compared to well-controlled epilepsy patients and healthy control groups, while MPV and albumin levels were found to be significantly lower. Conclusions: Serum CRP and CAO were found to be significantly higher in refractory epilepsy patients compared to well-controlled epilepsy patients and healthy control groups, while MPV and albumin levels were found to be significantly lower. In addition, this inflammatory activity increases as the frequency of seizures increases and the duration of the disease increases. These findings suggest that increased inflammatory response may affect the patient’s prognosis. In light of these findings, we think new treatment strategies that control the inflammatory response are necessary for patients with refractory epilepsy.
期刊介绍:
Neurology Asia (ISSN 1823-6138), previously known as Neurological Journal of South East Asia (ISSN 1394-780X), is the official journal of the ASEAN Neurological Association (ASNA), Asian & Oceanian Association of Neurology (AOAN), and the Asian & Oceanian Child Neurology Association. The primary purpose is to publish the results of study and research in neurology, with emphasis to neurological diseases occurring primarily in Asia, aspects of the diseases peculiar to Asia, and practices of neurology in Asia (Asian neurology).